mRNA-1010 superior to standard-dose vaccine for preventing flu, finds study
For adults aged 50 years or older, an investigational messenger RNA (mRNA)-based vaccine (mRNA-1010) is superior to standard-dose licensed vaccines for preventing influenza-like illness, according to a study published in ...
May 7, 2026
0
5









